For the fourth consecutive year, Ichilov leads all Israeli hospitals in both: The highest number of clinical research studies submitted, and The largest research-related income, surpassing ₪167 million in 2024 alone.

I-NEXT is Ichilov’s innovation center, where next -generation research, technology, and clinical expertise come together to transform healthcare.
By bridging the gap between clinicians, entrepreneurs, and industry leaders, I-NEXT accelerates the journey from idea to real-world impact developing AI-driven solutions, pioneering personalized medicine, and driving breakthroughs that improve patient care.
With a strong global network and a vision for the future, I-NEXT is shaping the next era of health innovation, today. 

At I-NEXT:

Research Laboratories

Affiliated with Tel Aviv University and an array of international associations, basic and translational research at Ichilov is cutting edge, globally relevant, and collaborative, ensuring our discoveries reach patients and advance health.

Clinical Trials

Translating Discovery into Better Patient Care Streamlining communication and collaboration for the advancement of health solutions and effective patient-care.

I-NEXT DATA AI Center

I-Next Data is a leading Center of Excellence for Applied Medical AI, integrating AI based solutions into all parts of the healthcare organization workflow, and cultivating networks that will make the benefits of the AI healthcare revolution truly accessible to patients and caregivers worldwide

I-NEXT Tech | Ichilov Tech

Ichilov hospital's innovation company, curates design partnerships with Israel's entrepreneurial ecosystem to advance HealthTech innovation. Ichilov Tech streamlines collaboration between the hospital and the external startup and corporate community

I-NEXT SURGICAL

Bringing surgery into the next dimension The Levin Center for 3D Printing and Surgical Innovation develops and delivers next-generation 3D solutions to help perfect personalized patient care.

TLV BioBank - The Institutional Biobank

he Institutional Tissue Bank (Institutional BioBank) is set to serve as an advanced infrastructure for scientific research conducted in academia and industry in Israel and around the world.

I-ACT: From Discovery to Treatment

he main objective of I-ACT is to enable, embed and facilitate clinical research projects and programs involving the delivery of Advanced Cellular Therapies.

Helsinki Committee

The committee adheres to strict ethical and operational guidelines, including those issued by the International Conference on Harmonization (ICH-GCP).

Research Laboratories - Translational Research

Each of our 56 research labs is connected to a clinical department, ensuring accelerated collaboration between physicians and researchers in order to streamline research, development, and delivery.
Advancing Health through Discovery >>

What We Do at INEXT DATA AI Center

CLINICAL DECISION SUPPORT SYSTEMS (DSS)

From insight to impact: elevating medical decisions with precision Read More

DATA PLATFORM FOR CLINICAL RESEARCH

A unified data platform for scalable clinical and research innovation Read More

EFFICIENT & EFFECTIVE DATA DRIVEN SOLUTIONS FOR CLINICIANS

Data-driven solutions designed to make healthcare smarter, more efficient, and focused on what truly matters. Read More

SANDBOX FOR MEDICAL STARTUPS

Where data, expertise and innovation unite Read More

WORLDWIDE COMMUNITY OF HOSPITALS FOR MEDICAL INNOVATION

A Global hub for medical knowledge and innovation Read More

FACILITATING DATA ACCESS FOR CLINICAL RESEARCH PURPOSES

Providing streamlined and secure data access solutions that support clinical research initiatives Read More

I-NEXT Leadership

More Info

Prof. David Zeltser

Deputy Director, R&D and Innovation. Director, Internal Medicine Division

Contact Info
Tel: +97236973814
Mail:  mop@tlvmc.gov.il
Address: Arison Medical Tower | Floor 33 |
6 Weizmann Street | Tel-Aviv Israel,64239

At Ichilov, research is personal. It’s about bringing tomorrow’s breakthroughs to the people who need them — 𝗻𝗼𝘁 𝗼𝗻𝗲 𝗱𝗮𝘆, 𝗯𝘂𝘁 𝘁𝗼𝗱𝗮𝘆.